Lewis S Blevins, MD
Endocrinology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 3
- Since medical school
- 39 years
- Graduated 1987
Offices
3 locations · UCSF Medical Group Business Services · University of California San Francisco
Hospitals listed: Marian Regional Medical Center · Marinhealth Medical Center · Mills-Peninsula Medical Center · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Blevins’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G87956 · Current
Licensed to practise in California · since 2007 · expires 2028-07-31 · East Tennessee State University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Tennessee 30028Medical Doctor · since 1997 · expires 2007-07-31Specialty on the licence: Endocrinology Diabetes and MetabolismVoluntarily RetiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
Education
- Etsu · MDJOHNSON CITY TN · 1987Medical school
Residency and fellowship
- Johns Hopkins Endocrine FellowshipBALTIMORE MD · 1990–1993
- Uab Hosp Med ResBIRMINGHAM AL · 1987–1990
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marian Regional Medical CenterSanta Maria, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.67 (0.37 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.081, Oct 2024 – Sep 2025
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marian Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.67 (0.37 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.081 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0.06 to 1.93) · 1,191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 189.73 (139.29 to 240.17) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.9 · 247 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 478 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 470 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 237 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,050 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 8,823 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.42) · 8,672 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.87 (0.97 to 4.76) · 2,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.12 (0.57 to 3.67) · 782 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.85 to 3.72) · 1,934 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.63 (0 to 9.97) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (1.37 to 8.65) · 748 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.88 (0.43 to 3.32) · 373 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.73) · 6,968 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 179 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.245 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.85 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.952 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.687 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 198 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 469 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.8 · 232 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.8 · 541 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.6 · 473 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 434 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5 to 8.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (8.8 to 13.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 17) · 124 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 638 cases | No different | Jan 2024 – Dec 2024 |
What patients said (666 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$32,373
Medicare paid this office $32,373 for 338 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 236 | $21,851 | $73 |
| New patient visit (45+ min) | 60 | $6,266 | $104 |
| Telephone medical discussion with physician, 11-20 minutes | 34 | $2,113 | $54 |
| Short return visit (20+ min) | 16 | $998 | $55 |
Who their Medicare patients are
338 Original Medicare patients in 2024. Average age 71 · Under 65 14% · 85 and older 4% · Women 51% · Also on Medicaid 19% · Health risk score 1.25. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 62% · Diabetes 27% · Coronary heart disease 22% · Depression 20% · Chronic kidney disease 18% · Cancer 13% · Heart failure 9% · COPD 9% · Atrial fibrillation 9% · Stroke 9% · Dementia 4%.
The office billed $243,029, Medicare allowed $47,071 and paid $32,373; for 439 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 338 | 439 | 71 | 1.25 | $243,029 | $32,373 |
| 2023 | 323 | 693 | 70 | 1.23 | $351,469 | $44,034 |
| 2022 | 295 | 492 | 69 | 1.17 | $253,426 | $32,880 |
| 2021 | 267 | 404 | 69 | 1.21 | $222,364 | $30,812 |
| 2020 | 207 | 273 | 68 | 1.19 | $114,362 | $13,024 |
| 2019 | 183 | 239 | 68 | 1.19 | $105,842 | $11,355 |
| 2018 | 188 | 279 | 68 | 1.22 | $114,405 | $13,019 |
| 2017 | 193 | 268 | 68 | 1.30 | $101,582 | $11,525 |
| 2016 | 193 | 284 | 66 | 1.26 | $113,131 | $13,463 |
| 2015 | 186 | 288 | 66 | 1.21 | $112,395 | $13,548 |
| 2014 | 157 | 237 | 66 | 1.07 | $92,900 | $11,574 |
| 2013 | 123 | 181 | 65 | 0.98 | $65,627 | $8,764 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 228 | $21,404 | $73 |
| New patient visit (45+ min) | 76 | $8,793 | $116 |
| Short return visit (20+ min) | 28 | $1,496 | $47 |
| Telephone medical discussion with physician, 21-30 minutes | 18 | $1,377 | $77 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $993 | $52 |
2022: 5 services
| Return visit (30+ min) | 205 | $19,310 | $73 |
| New patient visit (45+ min) | 55 | $6,004 | $109 |
| Telephone medical discussion with physician, 11-20 minutes | 39 | $2,074 | $45 |
| Short return visit (20+ min) | 25 | $1,308 | $48 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,048 | $87 |
2021: 4 services
| Return visit (30+ min) | 172 | $18,558 | $77 |
| New patient visit (45+ min) | 62 | $6,502 | $105 |
| Short return visit (20+ min) | 45 | $3,099 | $56 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $1,888 | $52 |
2020: 4 services
| Short return visit (20+ min) | 131 | $6,834 | $42 |
| Return visit (30+ min) | 35 | $2,318 | $63 |
| New patient visit (30+ min) | 33 | $1,972 | $60 |
| Telephone medical discussion with physician, 11-20 minutes | 20 | $902 | $45 |
2019: 4 services
| Short return visit (20+ min) | 123 | $6,411 | $42 |
| New patient visit (30+ min) | 57 | $3,440 | $60 |
| Return visit (30+ min) | 11 | $746 | $68 |
| New patient visit (15+ min) | 11 | $502 | $46 |
2018: 4 services
| Short return visit (20+ min) | 136 | $6,429 | $39 |
| New patient visit (30+ min) | 55 | $3,366 | $61 |
| Return visit (30+ min) | 25 | $1,702 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $623 | $35 |
2017: 3 services
| Short return visit (20+ min) | 141 | $7,107 | $38 |
| New patient visit (30+ min) | 42 | $2,642 | $63 |
| New patient visit (15+ min) | 17 | $757 | $45 |
2016: 3 services
| Short return visit (20+ min) | 143 | $8,088 | $41 |
| New patient visit (30+ min) | 62 | $4,035 | $65 |
| Return visit (30+ min) | 11 | $628 | $57 |
2015: 2 services
| Short return visit (20+ min) | 139 | $8,207 | $41 |
| New patient visit (30+ min) | 71 | $4,313 | $61 |
2014: 3 services
| Short return visit (20+ min) | 102 | $5,547 | $40 |
| New patient visit (30+ min) | 69 | $4,419 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $772 | $64 |
2013: 3 services
| Short return visit (20+ min) | 79 | $4,060 | $40 |
| New patient visit (30+ min) | 51 | $3,127 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $940 | $63 |
Medicaid work
$20,110 in 2024
Medicaid paid $20,110 for 378 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 184 | $18,664 |
| Telehealth transmission, per minute, professional services bill separately | 194 | $1,445 |
| 2024 | 378 | 2 | 27 | $20,110 |
| 2023 | 483 | 3 | 27 | $22,644 |
| 2022 | 442 | 3 | 22 | $18,240 |
| 2021 | 168 | 2 | 18 | $11,013 |
| 2020 | 156 | 3 | 19 | $4,432 |
| 2019 | 71 | 1 | 21 | $3,150 |
| 2018 | 16 | 1 | 14 | $824 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 208 | $18,372 |
| Telehealth originating site facility fee | 62 | $2,687 |
| Telehealth transmission, per minute, professional services bill separately | 213 | $1,585 |
2022
| Return visit (30+ min) | 150 | $12,530 |
| Telehealth originating site facility fee | 113 | $4,406 |
| Telehealth transmission, per minute, professional services bill separately | 179 | $1,304 |
2021
| Return visit (30+ min) | 118 | $8,976 |
| Telehealth originating site facility fee | 50 | $2,037 |
2020
| Short return visit (20+ min) | 88 | $3,441 |
| Telehealth originating site facility fee | 17 | $750 |
| Telehealth transmission, per minute, professional services bill separately | 51 | $242 |
2019
| Short return visit (20+ min) | 71 | $3,150 |
2018
| Short return visit (20+ min) | 16 | $824 |
Drugs they prescribed that Part D paid
$1,142,402
Pharmacies billed $1,142,402 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,520) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
747 generic and 681 brand-name prescriptions · $1,142,402 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Norditropin Flexpro | 164 | $334,279 | $2,038 |
| Genotropin | 167 | $287,718 | $1,723 |
| Omnitrope | 105 | $226,374 | $2,156 |
| Nutropin Aq Nuspin | 48 | $80,873 | $1,685 |
| Humatrope | 11 | $39,762 | $3,615 |
See all 16 drugs
| Norditropin Flexpro | 164 | $334,279 | $2,038 |
| Genotropin | 167 | $287,718 | $1,723 |
| Omnitrope | 105 | $226,374 | $2,156 |
| Nutropin Aq Nuspin | 48 | $80,873 | $1,685 |
| Humatrope | 11 | $39,762 | $3,615 |
| Testosterone | 142 | $22,692 | $160 |
| Cabergoline | 46 | $6,431 | $140 |
| Ultra-Fine Short Pen Needle | 71 | $4,062 | $57 |
| Levothyroxine | 266 | $3,561 | $13 |
| Synthroid | 30 | $1,851 | $62 |
| Desmopressin Acetate | 18 | $1,788 | $99 |
| Dexamethasone | 232 | $1,591 | $7 |
| Hydrocortisone | 39 | $1,538 | $39 |
| Testosterone Cypionate | 41 | $1,475 | $36 |
| Liothyronine | 26 | $1,323 | $51 |
| Desmopressin Acetate | 25 | $1,271 | $51 |
Year by year
| 2024 | 1,520 | 237 | 0% (0) | 45% | $1,142,402 |
| 2023 | 2,066 | 249 | 0% (0) | 49% | $1,807,383 |
| 2022 | 865 | 160 | 0% (0) | 52% | $740,549 |
| 2021 | 112 | 46 | 0% (0) | 58% | $88,208 |
| 2020 | 95 | 25 | 0% (0) | None | $29,435 |
| 2019 | 178 | 33 | 0% (0) | 39% | $21,464 |
| 2018 | 657 | 112 | 0% (0) | 58% | $442,247 |
| 2017 | 1,251 | 145 | 0% (0) | 60% | $985,080 |
| 2016 | 378 | 89 | 0% (0) | 51% | $184,613 |
| 2015 | 136 | 31 | 0% (0) | 72% | $84,009 |
| 2014 | 137 | 32 | 0% (0) | 65% | $84,467 |
| 2013 | 257 | 37 | 0% (0) | 63% | $163,727 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Genotropin | 329 | $569,913 | $1,732 |
| Omnitrope | 148 | $311,333 | $2,104 |
| Norditropin Flexpro | 112 | $269,954 | $2,410 |
| Nutropin Aq Nuspin | 138 | $221,486 | $1,605 |
| Somavert | 25 | $188,573 | $7,543 |
| Isturisa | 14 | $114,552 | $8,182 |
| Humatrope | 12 | $42,391 | $3,533 |
| Testosterone | 135 | $34,380 | $255 |
| Cabergoline | 63 | $9,153 | $145 |
| Levothyroxine | 335 | $7,685 | $23 |
| Desmopressin Acetate | 31 | $6,996 | $226 |
| Liothyronine | 59 | $3,113 | $53 |
| Ultra-Fine Short Pen Needle | 48 | $2,914 | $61 |
| Hydrocortisone | 44 | $2,860 | $65 |
| Synthroid | 36 | $2,774 | $77 |
| Dexamethasone | 333 | $2,391 | $7 |
| Desmopressin Acetate | 24 | $2,336 | $97 |
| Testosterone Cypionate | 49 | $1,846 | $38 |
| Fludrocortisone Acetate | 17 | $1,215 | $71 |
| Solu-Cortef | 11 | $808 | $73 |
| Techlite Pen Needle | 11 | $209 | $19 |
| Medroxyprogesterone Acetate | 13 | $143 | $11 |
2022: 17 drugs
| Genotropin | 123 | $257,234 | $2,091 |
| Omnitrope | 57 | $97,647 | $1,713 |
| Somavert | 17 | $89,882 | $5,287 |
| Norditropin Flexpro | 42 | $75,480 | $1,797 |
| Nutropin Aq Nuspin | 39 | $57,993 | $1,487 |
| Testosterone | 41 | $8,446 | $206 |
| Cabergoline | 37 | $7,846 | $212 |
| Levothyroxine | 167 | $3,972 | $24 |
| Desmopressin Acetate | 18 | $2,784 | $155 |
| Liothyronine | 24 | $2,029 | $85 |
| Synthroid | 21 | $2,025 | $96 |
| Hydrocortisone | 27 | $1,264 | $47 |
| Desmopressin Acetate | 15 | $1,117 | $74 |
| Dexamethasone | 126 | $696 | $6 |
| Ultra-Fine Short Pen Needle | 11 | $613 | $56 |
| Testosterone Cypionate | 21 | $586 | $28 |
| Medroxyprogesterone Acetate | 11 | $50 | $5 |
2021: 3 drugs
| Omnitrope | 19 | $35,308 | $1,858 |
| Levothyroxine | 32 | $983 | $31 |
| Dexamethasone | 15 | $79 | $5 |
2020: 2 drugs
| Levothyroxine | 42 | $801 | $19 |
| Dexamethasone | 12 | $80 | $7 |
2019: 4 drugs
| Cabergoline | 28 | $3,661 | $131 |
| Levothyroxine | 57 | $1,353 | $24 |
| Liothyronine | 14 | $511 | $37 |
| Dexamethasone | 36 | $191 | $5 |
2018: 12 drugs
| Norditropin Flexpro | 59 | $126,127 | $2,138 |
| Androgel | 83 | $78,888 | $950 |
| Omnitrope | 30 | $49,856 | $1,662 |
| Nutropin Aq Nuspin | 40 | $48,335 | $1,208 |
| Genotropin | 34 | $42,171 | $1,240 |
| Cabergoline | 48 | $10,590 | $221 |
| Levothyroxine | 120 | $2,681 | $22 |
| Desmopressin Acetate | 18 | $1,706 | $95 |
| Dexamethasone | 114 | $582 | $5 |
| Testosterone Cypionate | 21 | $401 | $19 |
| Hydrocortisone | 19 | $352 | $19 |
| Fludrocortisone Acetate | 11 | $132 | $12 |
2017: 12 drugs
| Norditropin Flexpro | 131 | $226,930 | $1,732 |
| Omnitrope | 137 | $211,855 | $1,546 |
| Nutropin Aq Nuspin | 109 | $200,373 | $1,838 |
| Humatrope | 46 | $93,631 | $2,035 |
| Androgel | 104 | $86,423 | $831 |
| Genotropin | 63 | $78,572 | $1,247 |
| Cabergoline | 58 | $14,306 | $247 |
| Levothyroxine | 220 | $5,425 | $25 |
| Neomycin-Polymyxin-Hc | 16 | $1,706 | $107 |
| Dexamethasone | 216 | $1,299 | $6 |
| Hydrocortisone | 27 | $600 | $22 |
| Testosterone Cypionate | 27 | $333 | $12 |
2016: 9 drugs
| Omnitrope | 52 | $58,176 | $1,119 |
| Nutropin Aq Nuspin | 37 | $38,681 | $1,045 |
| Norditropin Flexpro | 26 | $31,145 | $1,198 |
| Humatrope | 14 | $23,961 | $1,711 |
| Genotropin | 12 | $17,041 | $1,420 |
| Androgel | 11 | $6,319 | $574 |
| Cabergoline | 32 | $4,420 | $138 |
| Levothyroxine | 65 | $1,294 | $20 |
| Dexamethasone | 67 | $417 | $6 |
2015: 6 drugs
| Omnitrope | 40 | $36,026 | $901 |
| Norditropin Flexpro | 24 | $24,034 | $1,001 |
| Genotropin | 11 | $12,037 | $1,094 |
| Cabergoline | 11 | $970 | $88 |
| Levothyroxine | 15 | $296 | $20 |
| Dexamethasone | 14 | $92 | $7 |
2014: 6 drugs
| Norditropin Flexpro | 19 | $22,130 | $1,165 |
| Omnitrope | 26 | $19,836 | $763 |
| Genotropin | 13 | $11,213 | $863 |
| Cabergoline | 14 | $1,519 | $109 |
| Hydrocortisone | 12 | $342 | $29 |
| Dexamethasone | 18 | $108 | $6 |
2013: 8 drugs
| Norditropin Flexpro | 48 | $49,327 | $1,028 |
| Humatrope | 15 | $20,304 | $1,354 |
| Omnitrope | 30 | $18,500 | $617 |
| Androgel | 28 | $15,459 | $552 |
| Cabergoline | 19 | $2,144 | $113 |
| Hydrocortisone | 13 | $434 | $33 |
| Levothyroxine | 28 | $305 | $11 |
| Dexamethasone | 43 | $224 | $5 |
Money from drug and device companies
$21,297 in 2025
| 2025 | 5 | 21 | $19,697 | $21,297 |
| 2024 | 4 | 14 | $11,193 | $12,825 |
| 2023 | 3 | 27 | $20,199 | $26,264 |
| 2022 | 3 | 14 | $24,087 | $26,412 |
| 2021 | 5 | 21 | $41,438 | $41,438 |
| 2020 | 4 | 23 | $17,168 | $21,501 |
| 2019 | 6 | 18 | $14,493 | $16,140 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Recordati Rare Diseases Inc. | Isturisa | $14,832 | 12 payments
|
| Corcept Therapeutics | Korlym | $3,663 | 5 payments
|
| Rhythm Pharmaceuticals | None | $2,579 | 1 payment
|
| Xeris Pharmaceuticals | Recorlev | $124 | 2 payments
|
| Ascendis Pharma Endocrinology | Skytrofa | $99 | 1 payment
|
See all 21 published payments
| Xeris Pharmaceuticals | Meals · 2025-12-11 | Recorlev | $45 |
| Rhythm Pharmaceuticals | Honoraria · 2025-12-03 | None | $2,579 |
| Recordati Rare Diseases Inc. | Meals · 2025-10-23 | Isturisa | $104 |
| Recordati Rare Diseases Inc. | Meals · 2025-10-10 | Isturisa | $132 |
| Recordati Rare Diseases Inc. | Travel · 2025-10-10 | Isturisa | $397 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-10-09 | Isturisa | $3,600 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-10-08 | Isturisa | $3,300 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-10-07 | Isturisa | $2,100 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-10-04 | Isturisa | $3,300 |
| Recordati Rare Diseases Inc. | Travel · 2025-10-04 | Isturisa | $198 |
| Recordati Rare Diseases Inc. | Travel · 2025-10-04 | Isturisa | $158 |
| Recordati Rare Diseases Inc. | Paid to speak or teach · 2025-10-04 | Isturisa | $43 |
| Corcept Therapeutics | Meals · 2025-07-11 | Korlym | $127 |
| Corcept Therapeutics | Meals · 2025-07-11 | Korlym | $163 |
| Corcept Therapeutics | Meals · 2025-07-11 | Korlym | $55 |
| Corcept Therapeutics | Meals · 2025-07-11 | Korlym | $43 |
| Ascendis Pharma Endocrinology | Meals · 2025-07-11 | Skytrofa | $99 |
| Corcept Therapeutics | Paid to speak or teach · 2025-07-02 | Korlym | $3,275 |
| Xeris Pharmaceuticals | Meals · 2025-05-27 | Recorlev | $79 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-05-02 | Isturisa | $1,200 |
| Recordati Rare Diseases Inc. | Honoraria · 2025-03-17 | Isturisa | $300 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $12,825
| Recordati Rare Diseases Inc. | Isturisa | $9,868 | 8 payments
|
| Corcept Therapeutics | Korlym | $2,750 | 2 payments
|
| Xeris Pharmaceuticals | Recorlev | $157 | 3 payments
|
| Novo Nordisk | Sogroya | $50 | 1 payment
|
2023: $26,264
| Corcept Therapeutics | Korlym | $26,039 | 23 payments
|
| Chiesi USA | None | $114 | 1 payment
|
| Novo Nordisk | Sogroya | $112 | 3 payments
|
2022: $26,412
| Corcept Therapeutics | Korlym | $21,555 | 12 payments
|
| BioMarin Pharmaceutical | Palynziq | $2,457 | 1 payment
|
| Recordati Rare Diseases Inc. | Isturisa | $2,400 | 1 payment
|
2021: $41,438
| Corcept Therapeutics | Korlym | $29,803 | 13 payments
|
| Chiasma | Mycapssa | $5,710 | 4 payments
|
| Recordati Rare Diseases Inc. | None | $2,750 | 1 payment
|
| Genentech USA | Nutropin Aq Nuspin 5 | $1,925 | 2 payments
|
| Pfizer | Somavert | $1,250 | 1 payment
|
2020: $21,501
| Corcept Therapeutics | Korlym | $9,060 | 12 payments
|
| Novo Nordisk | Macrilen | $6,589 | 8 payments
|
| Genentech USA | Nutropin Aq Nuspin 5 | $4,365 | 2 payments
|
| Ipsen Biopharmaceuticals | Somatuline Depot | $1,488 | 1 payment
|
2019: $16,140
| Novo Nordisk | Norditropin | $8,345 | 7 payments
|
| Corcept Therapeutics | Korlym | $5,930 | 6 payments
|
| Genentech USA | Nutropin Aq Nuspin 5 | $1,698 | 1 payment
|
| Strongbridge US | Keveyis | $91 | 2 payments
|
| Ipsen Biopharmaceuticals | Increlex | $43 | 1 payment
|
| Pfizer | Somavert | $33 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1295822393
- Licence
- CA G87956, TN MD30028California G87956: Current · expires 2028-07-31Tennessee 30028: Voluntarily Retired
- Group
- UCSF Medical Group Business Services · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 400 Parnassus Ave # A808, San Francisco, CA, 94143
- NPI first listed
- 2006-10-09
- NPI last updated
- 2023-08-04
- NPI record certified
- 2023-08-04
This is when the NPI record was last certified, not a medical board exam.